Key result
AI model using preoperative sRAGE predicts post-CABG depression with ~62% accuracy.
Why the study?
Comorbid depression affects approximately one-third of individuals with cardiovascular disease and significantly increases cardiac complications and mortality, prompting the need for a data-driven predictive pipeline.
Can an AI-empowered predictive model using clinical and biomarker data accurately identify depression and predict postoperative delirium in patients scheduled for CABG?
Observational (n=224)
No
Can an AI-empowered predictive model using clinical and biomarker data accurately identify depression and predict postoperative delirium in patients scheduled for CABG?
Effect estimate: Accuracy 0.62, AUC 0.67
p-value: p=0.038
An AI-driven predictive model incorporating preoperative sRAGE levels and clinical data can predict depression and postoperative delirium with moderate accuracy in patients undergoing CABG.
Modest AI accuracy for preoperative depression prediction in CABG patients should not change practice; leaves open utility pending prospective validation.
Several studies have demonstrated a critical association between cardiovascular disease (CVD) and mental health, revealing that approximately one-third of individuals with CVD also experience depression. This comorbidity significantly increases the risk of cardiac complications and mortality, a risk that persists regardless of traditional factors. Addressing this issue, our study pioneers a straightforward, explainable, and data-driven pipeline for predicting depression in CVD patients. METHODS: Our study was conducted at a cardiac surgical intensive care unit. A total of 224 participants who were scheduled for elective coronary artery bypass graft surgery (CABG) were enrolled in the study. Prior to surgery, each patient underwent psychiatric evaluation to identify major depressive disorder (MDD) based on the DSM-5 criteria. An advanced data curation workflow was applied to eliminate outliers and inconsistencies and improve data quality. An explainable AI-empowered pipeline was developed, where sophisticated machine learning techniques, including the AdaBoost, random forest, and XGBoost algorithms, were trained and tested on the curated data based on a stratified cross-validation approach. RESULTS: = 0.038). Among the applied models, the random forest classifier demonstrated superior accuracy in predicting depression, with notable scores in accuracy (0.62), sensitivity (0.71), specificity (0.53), and area under the curve (0.67). CONCLUSIONS: This study provides compelling evidence that depression in CVD patients, particularly those with elevated "sRAGE" levels, can be predicted with a 62% accuracy rate. Our AI-driven approach offers a promising way for early identification and intervention, potentially revolutionizing care strategies in this vulnerable population.
No takes yet. Share an insight, caveat, or question.
Nowakowska et al. (2023) conducted an observational in Cardiovascular disease scheduled for CABG (n=224). AI-empowered predictive pipeline using preoperative biomarkers (including sRAGE) was evaluated on Prediction of depression (Accuracy 0.62, AUC 0.67, p=0.038). An AI-driven random forest classifier using preoperative sRAGE levels predicted depression with 62% accuracy (AUC 0.67) in patients undergoing coronary artery bypass graft surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: